CDH5 and cancer: Studies had addressed the breakdown of VE-cadherin during EndMT led to altered vascular permeability and remolding, which were associated with many disease processes including angiogenesis, ischemia-reperfusion injury, inflammation, and cancer growth and metastasis [36, 37].